Title : Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.

Pub. Date : 2021 Jan 21

PMID : 32396609






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As shown with immunoblots and ELISA, empagliflozin significantly suppressed increased levels of ICAM-1,VCAM-1,TNF-alpha,IL-6 in human and murine HFpEF myocardium and attenuated pathological oxidative parameters (H2O2, 3-nitrotyrosine, GSH, lipid peroxide) in both cardiomyocyte cytosol and mitochondria in addition to improved endothelial vasorelaxation. empagliflozin vascular cell adhesion molecule 1 Homo sapiens